Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation.
Ontology highlight
ABSTRACT: Small molecules that promote the formation of new myelinating oligodendrocytes from oligodendrocyte progenitor cells (OPCs) are potential therapeutics for demyelinating diseases. We recently established inhibition of specific cholesterol biosynthesis enzymes and resulting accumulation of 8,9-unsaturated sterols as a unifying mechanism through which many such molecules act. To identify more potent sterol enhancers of oligodendrocyte formation, we synthesized a collection of 8,9-unsaturated sterol derivatives and found that 24,25-epoxylanosterol potently promoted oligodendrocyte formation. In OPCs, 24,25-epoxylanosterol was metabolized to 24,25-epoxycholesterol via the epoxycholesterol shunt pathway. Increasing flux through the epoxycholesterol shunt using genetic manipulation or small-molec
SUBMITTER: Hubler Z
PROVIDER: S-EPMC8217109 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA